Allscripts Healthcare Solutions Inc

Visual Financials
Company Name: Allscripts Healthcare Solutions Inc
Ticker Symbol: MDRX
CIK Number: 0001124804
WWW Address: http://www.allscripts.com
CEO: Paul M. Black
No. of Employees: 7,500
Common Issue Type: CS
Business Description:Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes.

 
Industry Information: HEALTH SERVICES - Medical Appliances & Equipment [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 11.24 Down -0.08 9.6 12.5 11.33 10.47 10.22 2078295
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,870.8 166.4 0.00 2.07 0.00 4.9 0.0 14.97 - 8.54
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close10.26$
PE Ratio - LTM4.9
Market Capitalisation1,870.8mil
Latest Shares Outstanding166.4mil
Earnings pS (EPS)2.07$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee184,207$
Effective Tax Rate0.0%
Float94.2mil
Float as % of Shares Outstanding0.6%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin41.4%
EBITDA Margin14.7%
Pre-Tax Profit Margin0.0%
Assets Turnover47.2%
Return on Assets (ROA)9.8%
Return on Equity (ROE)27.2%
Return on Capital Invested (ROCI)16.8%
Current Ratio1.1
Leverage Ratio (Assets/Equity)2.1
Interest Cover1.3
Total Debt/Equity (Gearing Ratio)0.43
LT Debt/Total Capital29.0%
Working Capital pS0.37$
Cash pS0.00$
Book-Value pS8.75$
Tangible Book-Value pS-2.78$
Cash Flow pS0.09$
Free Cash Flow pS-0.73$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.16
Price/Tangible Book Ratio0.00
Price/Cash Flow116.3
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---5.41,687,5137,576,721
4 Weeks10.669.6810.33-0.71,645,55031,265,458
13 Weeks10.789.1810.250.11,682,091105,971,737
26 Weeks12.408.549.498.12,276,164282,244,344
52 Weeks14.978.5412.62-18.72,024,200506,050,165
YTD12.409.18-4.92,133,104230,375,277
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
10.1410.149.9510.3911.330.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.050.30.08
Income0.6
Dividend0.0
Capital Spending-0.03NA-0.32
R&D0.00NA54.32
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-4.8-4.80.2
Earnings %0.00.00.0
EPS %-100.0-100.0-100.0
EPS $-0.10-0.10-0.40
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio1.92
Current Ratio1.1
Quick Ratio (Acid Test)0.9
Liquidity Ratio (Cash)0.45
Receivables Turnover3.4
Average Collection Period106
Working Capital/Equity3.9
Working Capital pS0.36
Cash-Flow pS0.38
Free Cash-Flow pS-0.43
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.87
Financial Leverage Ratio (Assets/Equity)0.4
Debt Ratio21.0
Total Debt/Equity (Gearing Ratio)0.43
LT Debt/Equity0.42
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities96.7
Interest Cover1.3
Interest/Capital Invested3.28
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.53
Current P/E Ratio - LTM4.90
Enterprise Value (EV)/EBITDA5.21
Enterprise Value (EV)/Free Cash Flow-40.23
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM1.16
Price/Cash Flow Ratio116.3
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM43.1
P/E Ratio (52 weeks ago) - LTM31.1
5-Y High P/E Ratio85.9
5-Y Low P/E Ratio42.7
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E-21
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS5.75
Current Liabilities pS7.08
Tangible Book Value pS - LTM-2.78
Book Value pS - LTM8.75
Capital Invested pS13.33
Cash pS - LTM0.00
Cash Flow pS - LTM0.09
Free Cash Flow pS - LTM-0.73
Earnings pS (EPS)2.07
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-4.38
Free Cash Flow Margin 5YEAR AVG4.46
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity1.13
Return on Equity (ROE)0.3
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.79
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.50
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin41.4
Gross Profit Margin - 5YEAR AVRG.0.4
EBITDA Margin - LTM14.7
EBIT Margin - LTM3.7
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate225.6
Effective Tax Rate - 5YEAR AVRG.45.1
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee184,207
Net Income per Employee43,404
Average Collection Period
Receivables Turnover3.4
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales4.18
Assets/Revenue2.00
Net Working Capital Turnover28.58
Fixed Assets Turnover0.75
Total Assets Turnover0.5
Revenue per $ Cash10.04
Revenue per $ Plant14.35
Revenue per $ Common Equity1.13
Revenue per $ Capital Invested0.79
Selling, General & Adm/tive (SG&A) as % of Revenue25.8
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue15.3
R&D Expense as % of Revenue - 5YEAR AVRG.15.3

  


Your Recent History
NASDAQ
MDRX
Allscripts..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.